Yongjian Zhou
No. 1 Panfu Road
Guangzhou, 510180, China
Guangzhou, 510180, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia.
Journal: American journal of hematology
Published: March 20, 2026
Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.
Journal: Clinical reviews in allergy & immunology
Published: March 03, 2026
Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study.
Journal: Journal of gastroenterology and hepatology
Published: December 20, 2025
Identification of the role of sugar-sweetened beverages in the progression of a murine metabolic dysfunction-associated steatotic liver disease model.
Journal: Frontiers in nutrition
Published: September 22, 2025
Fungal microbiota signatures anticipate neoadjuvant immunochemotherapy outcomes in esophageal cancer.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2025
Expert Consensus on Clinical Applications of Fecal Microbiota Transplantation for Chronic Liver Disease (2025 edition).
Journal: Journal of clinical and translational hepatology
Published: September 03, 2025
Dual roles of MAPK-mediated C/EBPβ phosphorylation in promoting maturation and suppressing EMT during hepatocyte differentiation from hESCs.
Journal: Stem cells (Dayton, Ohio)
Published: September 02, 2025
Dual-faced CXCL5 holds the key to unlocking immunotherapy in obese pancreatic cancer.
Journal: Journal for immunotherapy of cancer
Published: August 15, 2025
JMJD3-mediated HADH demethylation orchestrates hepatocyte maturation through fatty acid β-oxidation-dependent histone acetylation.
Journal: Experimental & molecular medicine
Published: August 12, 2025
Microbial Anti-Inflammatory Molecule (MAM) secreted by Faecalibacterium prausnitzii ameliorates colitis through autophagy and gut microbiota modulation.
Journal: Journal of translational medicine
Published: July 14, 2025
MicroRNA‑microbiome cross‑kingdom networks drive inflammatory bowel disease through dynamic regulatory ecosystems (Review).
Journal: International journal of molecular medicine
Published: July 03, 2025
Engineered probiotics: a new era in treating inflammatory bowel disease.
Journal: Journal of translational medicine
Published: July 02, 2025
Last Updated: 09/26/2026